One of Türkiye’s long-established pharmaceutical companies, Drogsan Pharmaceuticals, has announced a significant leadership transition. Dr. Sabri Öncel has been appointed as the company’s new Chief Executive Officer, effective March 9, 2026. Former CEO Dr. Ersan Küçük, who led the company for 18 years, will continue contributing as a strategic advisor.
Read More